The page is the record's research on the issuer — no analyst, no rating, no view. # Wave Life Sciences, Inc. (NASDAQ: WVE) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Wave Life Sciences, Inc., listed on NASDAQ under ticker WVE. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate and the segment is not on the record. The sector is 2834 Pharmaceutical Preparations and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 115 filings in the twelve months to 2026-11-08, across 42 filing days. Of these, 52 are regulatory filings, 33 are directors' dealings, 12 are results, 9 are corporate news, 6 are AGM or EGM notices, 2 are prospectuses and 1 is a halt or suspension. The median gap between filing days is 4 days. The latest filing is dated 2026-10-27 and is a regulatory filing, 12 days before the record date. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days. The 2834 Pharmaceutical Preparations median is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days. ## Auditor The auditor of record is not on the record, and its location is not on the record. The record holds no auditor changes, because the latest annual report cover carries no auditor name tag and foreign private issuers and older filings carry none. ## Events and halts The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line, and the segment move is not on the record, because exchange tier transfers are not EDGAR filings. The halt flag is clear: the issuer is listed and not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds the issuer's years 2021, 2022, 2023, 2024, 2025 and 2026 as sealed. The earliest sealed date of the US market is 2021-01-04. The live record began on 2026-09-12. ## Sources 6 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://data.sec.gov/submissions/CIK0001631574.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/WVE (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/WVE (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/WVE · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp